In principle, DOTA-PRIT consists of three sequential administrations of three reagents: (i) the bi-specific Ab construct IgG-scFv (bsAb), which has high specificity and affinity for both a tumor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback